ir.alk-abello.com
Investors | ALKThe Investor Relations website contains information about ALK business for stockholders, potential investors, and financial analysts.
http://ir.alk-abello.com/
The Investor Relations website contains information about ALK business for stockholders, potential investors, and financial analysts.
http://ir.alk-abello.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.6 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
9
SITE IP
206.200.251.19
LOAD TIME
0.629 sec
SCORE
6.2
Investors | ALK | ir.alk-abello.com Reviews
https://ir.alk-abello.com
The Investor Relations website contains information about ALK business for stockholders, potential investors, and financial analysts.
ir.alk-abello.com
Email alerts subscription | ALK
http://ir.alk-abello.com/profile.cfm
House dust mite allergy. What is allergic asthma. How is allergy diagnosed. Treating allergy and asthma. Annual general meeting (DK). ALK at a glance. Step 1 of 3: Select Options. You may automatically receive ALK financial information by email. Please enter your preferences for email notifications below and click Continue to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Send me the closing stock price.
ALK - Shareholder Briefcase Registration
http://ir.alk-abello.com/briefcase.cfm
Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. Please fill in the form below to access this feature. *. Fixed Income Analyst (sell-side). Fixed Income Analyst (buy-side). Portfolio Manager (Fixed Income). Type in number *. This helps ALK prevent automated submissions.
ALK's partner for Japan reports positive Phase II/III trial results for Japanese Cedar SLIT-tablet (OMX:ALKB)
http://ir.alk-abello.com/releasedetail.cfm?ReleaseID=926550
Laquo; Previous Release. Next Release ». August 7, 2015. ALK's partner for Japan reports positive Phase II/III trial results for Japanese Cedar SLIT-tablet. Copenhagen, 2015-08-07 09:00 CEST (GLOBE NEWSWIRE) -. ALK's President and CEO Jens Bager said: "These results mark another step on our journey towards globalising ALK's portfolio of SLIT-tablets. Our partnership with Torii continues to progress rapidly and we are getting closer to a launch of these products in the world's second largest pharmaceu...
ALK - Financial reporting - Latest full year accounts
http://ir.alk-abello.com/financials.cfm
Financial reporting - Latest full year accounts. Financial reporting - Latest full year accounts. ALK-Abelló A/S Bøge Allé 6 DK-2970 Hørsholm Denmark CVR no. 63717916 T 45 45 74 75 76.
ALK - Download Library
http://ir.alk-abello.com/downloads.cfm
Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files. IR presentation 07062016.pdf. Three-month interim report (Q1) 2016. Q1-2016Webcast 04052016 FINAL.pdf. Annual General Meeting 2016 Minutes. ALK GF pres 10 March 2016 1003 final.pdf. General IR presentation, February 2015. Showing 1-10 of 164. Add file to Briefcase.
TOTAL PAGES IN THIS WEBSITE
15
Investor Relations - Investor Relations
Your partner in aquaculture technology. AKVA group is the global leader in delivering technology to the aquaculture industry. The shares of AKVA group are traded on the Oslo Stock Exchange from November 2006. The company will strive to provide the market with relevant information according to the current regulations. It will always be an objective to give correct, relevant and timely information to all market participants at the same time. AKVA group ASA : 1Q 2015 financial reporting. Tel 47 916 39 831.
Investor Relations - Investor Relations - Albany International Corp.
Q2 2015 Albany International Corp Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Albany International Corp Earnings Conference Call. Wednesday, August 5, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. Q3 2014 Albany International Corp Earnings Conference Call. Tuesday, November 4, 2014 9:00 am ET. Q3 2014 Financial Results. Q3 2014 Earnings Call Presentation. Albany International Reports Second-Quarter Results. Tuesday, August 4, 2015 - 5:00 pm. Replicat...
Investors - Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is a clinical-stage biotechnology company focused primarily on the development of products to treat diseases thought to be related to endogenous free aldehydes, a naturally occurring class of toxic molecules. The company has developed NS2, a product candidate designed to trap free aldehydes. Aldeyra has initiated clinical testing of NS2 for the treatment of Sjögren-Larsson Syndrome and noninfectious anterior uveitis. Aldeyra Therapeutics Corporate Presentation - August 2015. Aldeyra ...
Alexion Pharmaceuticals, Inc. - Investor Relations
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Last $ 189.62. 080715 4:00 PM ET. Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015. Thu, 30 Jul, 2015 - 10:00 AM ET Listen to Webcast ». 2Q 2015 Earnings Slides. Please see Full Prescribing Information. And Important Safety Information.
Algodon Wines & Luxury Development Group, Inc.
Algodon Wine and Luxury Development Group. How to Invest with Us. Algodon Uncorks Preview of 2015 Wine Line and New Blend for Chinese Market. Dec 16, 2014. Located in the city's most elegant residential neighborhood of Recoleta, as well as the Mendoza wine resort called Algodon Wine Estates. Sign up for email alerts. Be the first to receive breaking news. All Securities offered through DPEC Capital, Inc. (Member FINRA.
Investors | ALK
House dust mite allergy. What is allergic asthma. How is allergy diagnosed. Treating allergy and asthma. Annual general meeting (DK). ALK at a glance. Grant of share options and performance shares to members of the Board of Management and key employees. Annual General Meeting in ALK-Abelló A/S held on 12 March 2018. New medicine for house dust mite allergic rhinitis and allergic asthma now available in France. ALK's partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan.
IR Portal // All for One Steeb
All for One Steeb. Social Media News Room. Nachhaltig und profitabel wachsen. Equity Story nachhaltiges Wertsteigerungspotenzial. Die All for One Steeb AG ist die Nummer 1. Im SAP-Markt in der deutschsprachigen Region und führendes IT-Haus:. Größte SAP Mittelstandskunden Basis mit Softwarewartungs- und Outsourcing/Cloud Services Verträgen. Hoher Anteil wiederkehrender Erlöse Treiber für Skaleneffekte, Profitabilität und Cash-Flow. Einzigartiges Geschäftsmodell stark fokussiert. Die All for One Steeb AG, ...
پورتال بیزنس ايران > بصورت جدید در https://ir.all.biz تجارت کن
مرکز جهانی تجارت اینترنتی. 1,4 million of companies and 16 million of custiomers around the world. Create a lead for. And sellers will contact you. Suppliers will contact you. لوازم خودرو و موتور. بصورت جدید در https:/ ir.all.biz تجارت کن". تجهیزات تامین آب، گاز و حرارت. بصورت جدید در https:/ ir.all.biz تجارت کن". چوب بست، تخته و الوار. بصورت جدید در https:/ ir.all.biz تجارت کن". وسایل خانه داری و باغداری. بصورت جدید در https:/ ir.all.biz تجارت کن". لوازم بهداشتی و آرایشی. محصولات غذایی و آشامیدنی. بصورت...
Investor Overview | Investor Relations | Allegiant Air
Skip to main content. We appreciate your interest in Allegiant. This site is designed to provide you up-to-date information on Allegiant Travel Company (ALGT), the parent company of Allegiant Air and Allegiant Vacations. 160; 3.96. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Allegiant Reports July 2015 Traffic. Allegiant Travel Company Second Quarter 2015 Financial Results. Untitled Document Click to Tweet: .@AllegiantTravel announces further expansion from @flymemphis with new flights t...
Investor Overview - Allergan
Applying to Allergan in the US. Read the full story. Allergan Acquisition: Investor Information. Executive Officers and Directors. Allergan’s U.S. Generics business continues to operate as Actavis. A global Growth Pharma leader. High priorities: sustainability and continual improvement. Patient Safety and Product Quality. California Supply Chain Disclosure. Actavis Completes Forest Laboratories Acquisition. The behaviors of all Actavis employees are defined by Our Winning Way. READ THE FULL STORY.
Alliqua BioMedical, Inc. (ALQA)
Alliqua in the News. Alliqua in the News. Alliqua BioMedical, Inc. to Attend 2015 Midwest IDEAS Investor Conference. Aug 13 2015, 7:30 AM EDT. 2015 Midwest IDEAS Investor Conference. Aug 27, 2015 1:50 pm CT. Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of. Advanced wound care solutions that will enable surgeons, clinicians, and. Wound care practitioners to address the entire spectrum of challenges. Presented by chronic and advanced wounds. Alliqua is building this portfolio.
SOCIAL ENGAGEMENT